Correlation Between Unrivaled Brands and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unrivaled Brands and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unrivaled Brands and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unrivaled Brands and Cannara Biotech, you can compare the effects of market volatilities on Unrivaled Brands and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unrivaled Brands with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unrivaled Brands and Cannara Biotech.

Diversification Opportunities for Unrivaled Brands and Cannara Biotech

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Unrivaled and Cannara is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Unrivaled Brands and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Unrivaled Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unrivaled Brands are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Unrivaled Brands i.e., Unrivaled Brands and Cannara Biotech go up and down completely randomly.

Pair Corralation between Unrivaled Brands and Cannara Biotech

Given the investment horizon of 90 days Unrivaled Brands is expected to generate 1.35 times more return on investment than Cannara Biotech. However, Unrivaled Brands is 1.35 times more volatile than Cannara Biotech. It trades about 0.03 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.0 per unit of risk. If you would invest  2.00  in Unrivaled Brands on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Unrivaled Brands or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy24.84%
ValuesDaily Returns

Unrivaled Brands  vs.  Cannara Biotech

 Performance 
       Timeline  
Unrivaled Brands 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Unrivaled Brands has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Unrivaled Brands is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Unrivaled Brands and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unrivaled Brands and Cannara Biotech

The main advantage of trading using opposite Unrivaled Brands and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unrivaled Brands position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind Unrivaled Brands and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine